Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis

Danny Luan, BS, MPH, Koen Van Besien, MD PhD, Paul J Christos, Dr.P.H., M.S., Roger Pearse, MD PhD, Danielle Guarneri, BS, CCRP, Morton Coleman, MD, Ruben Niesvizky, MD, Cara A. Rosenbaum, MD

Blood (2019) 134 (Supplement_1): 4579.

https://doi.org/10.1182/blood-2019-127723

Published: 2019

Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD

Blood (2019) 134 (Supplement_1): 5688.

https://doi.org/10.1182/blood-2019-127680

Published: 2019

Journal Articles

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Muhammad Aadil Rahman, MD, Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Asad Fraz, MD, Faiza Jamil, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2018-99-115214

Published: 2018

Journal Articles

Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101

Jing Fu, PhD, Alan Solomon, MD, Patrick Carberry, PhD, John Castrillon, Jongho Kim, MD PhD, Suzanne Lentzsch, MD PhD, Akiva Mintz, MD PhD

Blood (2018) 132 (Supplement 1): 1003.

https://doi.org/10.1182/blood-2018-99-118177

Published: 2018

Journal Articles

VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants

Cyrille Garnier, Fatma Briki, Brigitte Nedelec, Patrick Le Pogamp, Ahmet Dogan, Nathalie Rioux-Leclercq, Renan Goude, Caroline Beugnet, Laurent Martin, Marc Delpech, Frank Bridoux, Gilles Grateau, Jean Doucet, Philippe Derreumaux, Sophie Valleix

Blood (2017) 130 (25): 2799–2807.

https://doi.org/10.1182/blood-2017-07-796185

Published: 2017

Journal Articles

Four Cases of Lenalidomide-Associated Immune Thrombocytopenia

Alessandra Pompa, MD, Francesca Guidotti, MD, Anna Ines Gregorini, MD, Maria Cecilia Goldaniga, MD, Francesca Gaia Rossi, MD, Luca Baldini, MD Prof, Agostino Cortelezzi, MD

Blood (2016) 128 (22): 4927.

https://doi.org/10.1182/blood.V128.22.4927.4927

Published: 2016

Journal Articles

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Akhil Khera, Katja Kimberger, Fotios Panitsas, Chris Winearls, John Quinn, Simon Stern, Neil Rabin, Bassam Alchi, Ian Roberts, Richard Haynes, Karthik Ramasamy

Blood (2016) 128 (22): 5948.

https://doi.org/10.1182/blood.V128.22.5948.5948

Published: 2016

Journal Articles

Clinical and Cytogenetic Characterization of Light Chain Amyloidosis Patients with a Low Amyloidogenic Free Light Chain Count at First Diagnosis

Tobias Dittrich, MD, Ute Hegenbart, MD, Tilmann Bochtler, MD, Christoph Kimmich, MD, Anna Jauch, Prof., Arnt Kristen, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD, Stefan Schönland, MD

Blood (2015) 126 (23): 1790.

https://doi.org/10.1182/blood.V126.23.1790.1790

Published: 2015

Journal Articles

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Vinita Gupta, MD, Hulya Armutlugoynuk, MD, Anant Vatsayan, MD MBBS, Paolo F. Caimi, MD, Brenda Cooper, MD, Leland Metheny, MD, Ehsan Malek, MD, Erica L. Campagnaro, MD, Stan Gerson, MD, Marcos de Lima, MD, Hillard M. Lazarus, MD, Richard J Creger, PharmD

Blood (2015) 126 (23): 5491.

https://doi.org/10.1182/blood.V126.23.5491.5491

Published: 2015

Journal Articles

Renal Amyloidosis - Tempo of Proteinuria Resolution in Bortezomib Era

Henry Siu Him Chan, MBChB, Janak Rashme De Zoysa, David Simpson, MBChB, FRACP, FRCPA

Blood (2014) 124 (21): 5651.

https://doi.org/10.1182/blood.V124.21.5651.5651

Published: 2014

Journal Articles

Extent of Myeloma Cast-Nephropathy Correlates Well with Serum Creatinine: Findings from Autopsied Cases

Junichiro Takano, MD, Sohtaro MINE, MD BPharm, BA, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5700.

https://doi.org/10.1182/blood.V124.21.5700.5700

Published: 2014

Journal Articles

Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis

Peter Mollee, Patricia Renaut, Samuel Boros, Dorothy Loo, Michelle Hill

Blood (2013) 122 (21): 5295.

https://doi.org/10.1182/blood.V122.21.5295.5295

Published: 2013

Journal Articles

Renal Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Tait D Shanafelt, MD, Kari G. Rabe, Curtis A Hanson, MD, Timothy G. Call, MD, Susan Schwager, Sameer A. Parikh, MD, Samih H. Nasr, Nelson Leung, MD

Blood (2013) 122 (21): 5302.

https://doi.org/10.1182/blood.V122.21.5302.5302

Published: 2013

Journal Articles

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Sohtaro Mine, MD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD, Toru Igari, MD PhD

Blood (2013) 122 (21): 5321.

https://doi.org/10.1182/blood.V122.21.5321.5321

Published: 2013

Journal Articles

IgD Amyloidosis: An Unrecognized Entity

Morie Abraham Gertz, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., Angela Dispenzieri, Philip R. Greipp, MD, Shaji Kumar, Martha Q Lacy, MD, John A Lust, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Stephen J. Russell, MD, PhD, Steven R Zeldenrust, MD, PhD, Joseph R. Mikhael, MD, Vivek Roy, MD, FACP, Robert A Kyle, MD

Blood (2011) 118 (21): 5079.

https://doi.org/10.1182/blood.V118.21.5079.5079

Published: 2011

Journal Articles

Renal Involvement and Outcome In Monoclonal Lightchain Disease

Raoul Bergner, Michael J. Uppenkamp, Martin Hoffmann

Blood (2010) 116 (21): 4985.

https://doi.org/10.1182/blood.V116.21.4985.4985

Published: 2010

Journal Articles

Splenic Rupture as a Complication of Autologous Hematopoietic Cell Transplantation In a Patient with Systemic Amyloidosis.

Taiga Nishihori, MD, Noman Ashraf, MD, Estrella M. Carballido, MD, Timothy Yeatman, M.D., Lynn C. Moscinski, MD, Melissa Alsina, MD

Blood (2010) 116 (21): 4528.

https://doi.org/10.1182/blood.V116.21.4528.4528

Published: 2010

Journal Articles

A Pilot Study of Melphalan, Lenalidomide and Dexamethasone In AL Amyloidosis: Interim Results

Anosheh Afghahi, MD, Wesley Witteles, MD, Ronald Witteles, MD, Michaela Liedtke, MD, Richard Lafayette, MD, Sally Arai, MD, Stanley L. Schrier, MD

Blood (2010) 116 (21): 1946.

https://doi.org/10.1182/blood.V116.21.1946.1946

Published: 2010

Journal Articles

Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation

Arie J. Stangou, Nicholas R. Banner, Bruce M. Hendry, Mohamed Rela, Bernard Portmann, Julia Wendon, Mark Monaghan, Philip MacCarthy, Muriel Buxton-Thomas, Christopher J. Mathias, Juris J. Liepnieks, John O'Grady, Nigel D. Heaton, Merrill D. Benson

Blood (2010) 115 (15): 2998–3007.

https://doi.org/10.1182/blood-2009-06-223792

Published: 2010

Journal Articles

Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study.

Heinz Ludwig, MD, Zdenek Adam, MD, Roman Hajek, MD, Richard Greil, MD, Elena Tóthová, MD, Felix Keil, MD, Eva-Maria Autzinger, MD, Josef Thaler, MD, Heinz Gisslinger, MD, Alois Lang, MD, Miklós Egyed, MD, PhD, Niklas Zojer, MD

Blood (2009) 114 (22): 3862.

https://doi.org/10.1182/blood.V114.22.3862.3862

Published: 2009

NARROW

Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101

VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants

Four Cases of Lenalidomide-Associated Immune Thrombocytopenia

Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)

Clinical and Cytogenetic Characterization of Light Chain Amyloidosis Patients with a Low Amyloidogenic Free Light Chain Count at First Diagnosis

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Renal Amyloidosis - Tempo of Proteinuria Resolution in Bortezomib Era

Extent of Myeloma Cast-Nephropathy Correlates Well with Serum Creatinine: Findings from Autopsied Cases

Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis

Renal Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

IgD Amyloidosis: An Unrecognized Entity

Renal Involvement and Outcome In Monoclonal Lightchain Disease

Splenic Rupture as a Complication of Autologous Hematopoietic Cell Transplantation In a Patient with Systemic Amyloidosis.

A Pilot Study of Melphalan, Lenalidomide and Dexamethasone In AL Amyloidosis: Interim Results

Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation

Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only